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Abstract
Background: Microorganisms have been associated with many types of human diseases; however,
a significant number of clinically important microbial pathogens remain to be discovered.
Methods: We have developed a genome-wide approach, called Digital Karyotyping Microbe
Identification (DK-MICROBE), to identify genomic DNA of bacteria and viruses in human disease
tissues. This method involves the generation of an experimental DNA tag library through Digital
Karyotyping (DK) followed by analysis of the tag sequences for the presence of microbial DNA
content using a compiled microbial DNA virtual tag library.
Results: To validate this technology and to identify pathogens that may be associated with human
cancer pathogenesis, we used DK-MICROBE to determine the presence of microbial DNA in 58
human tumor samples, including brain, ovarian, and colorectal cancers. We detected DNA from
Human herpesvirus 6 (HHV-6) in a DK library of a colorectal cancer liver metastasis and in normal
tissue from the same patient.
Conclusion: DK-MICROBE can identify previously unknown infectious agents in human tumors,
and is now available for further applications for the identification of pathogen DNA in human cancer
and other diseases.
Background
Pathogens are involved in a variety of human diseases. Of
particular interest are emerging infections and idiopathic
chronic diseases, including cancer [1]. Nevertheless, clini-
cally important microbial pathogens in human disease are
likely to be under-recognized [2,3]. Infectious agents have
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been identified as pathogens in several human tumors,
accounting for approximately 20% of human cancers
worldwide [4]. However, this proportion accounts for
only a few known viral or bacterial agents. Emerging data
suggests the role of additional unknown microbes in tum-
origenesis [2]. Detection of these infectious agents could
provide novel approaches to the prevention, diagnosis
and therapy of human cancer.
In the search for the presence of pathogenic DNA in
human disease tissues, two kinds of approaches, candi-
date-based and subtractive, have been previously used.
Consensus polymerase chain reaction (PCR) [5-7] and
newer DNA microarray-based screening [8-11] methods
have been used for candidate-based foreign sequence
identification. Candidate screens employing PCR-based
techniques have been successfully used for identification
and typing of HPV in cervical cancer [12]. DNA microar-
rays composed of oligonucleotides corresponding to con-
served sequences of multiple viruses have been applied to
identify a new xenotropic murine leukemia virus-related
virus in human prostate tumor cells [8]. Subtractive meth-
ods, including representational difference analysis (RDA)
[13], computational subtraction [14-16], and digital tran-
script subtraction [17], have been used to filter sequence
data to identify non-human sequences. RDA has been
used in the identification of herpesvirus in Kaposi's sar-
coma [18], and a method based on long serial analysis of
gene expression (LongSAGE) [19,20], called digital tran-
scriptome subtraction (DTS), has been used to identify a
new polyomavirus in Merkel cell carcinoma [21].
While these methods have been successful in microbe
identification, current techniques have limitations. Can-
didate-based approaches only confirm the presence of
known viruses or bacteria [6]. In addition, varying mech-
anisms of infection confound the identification of foreign
transcript sequences, as the agent may remain in a latent
state for years in the host cell without being detected by
gene expression methods.
To overcome these limitations, we developed a pathogen
discovery approach that applies computational subtrac-
tion to Digital Karyotyping (DK). DK identifies and enu-
merates short sequence tags to provide a comprehensive
view of the genomic content of any DNA sample [22,23].
Generally, experimental tags obtained from a DK library
are matched to a virtual tag library derived from the
human genome. Although the vast majority of tags are
identical to the predicted virtual tags, there are inevitably
experimental tags which do not match any human
sequence. These sequences originate from a number of
sources, including unpublished human sequences, tag site
polymorphisms, sequencing errors, or foreign DNA
sequences that are not present in the normal human
genome.
We developed DK-MICROBE to quantitatively evaluate
DK sequences that do not match the human genome and
which may be derived from microbial genomic DNA. We
verified the sensitivity and specificity of this approach by
studying Epstein Barr virus (EBV)-infected human lym-
phoblastoid cells and murine retrovirus infected tumor
xenografts. We then applied this technique to analyze
brain, colorectal and ovarian tumors for viral and bacte-
rial genome sequences.
Methods
Tumor samples
The DK-MICROBE approach was designed for screening
of microbial DNA in cancer tissues. Brain tumor tissue
samples were obtained from the Preston Robert Tisch
Brain Tumor Center Biorepository at Duke University
Medical Center by an IRB-approved protocol. Frozen sec-
tions were made from each tumor sample and examined
by light microscopy by a board-certified neuropathologist
to ensure that more than 95% of the section consisted of
tumor cells.
Colorectal cancer DNA samples used to make Digital
Karyotyping libraries were derived from liver metastases
of different patients. Two of the samples were low-passage
cell lines established from liver metastasis, while seven
samples were immunopurified from liver metastases
using the BerEP4 antibody as previously described [24].
Additional samples used for qPCR confirmation were
low-passage xenografts established from liver metastases.
Normal DNA samples were obtained from peripheral
blood or adjacent normal liver.
Five of the ovarian cancer samples are from patients with
high-grade ovarian serous carcinoma. Two of the samples
are from cell lines purchased through ATCC. All samples
were obtained in accordance with the Health Insurance
Portability and Accountability Act (HIPAA).
DK-MICROBE experimental library generation
The initial aspects of performing DK-MICROBE are based
on Digital Karyotyping (DK) [25]. Briefly, genomic DNA
is cleaved with the mapping enzyme SacI, which has a 6-
bp recognition sequence that is predicted to cut genomic
DNA into several hundred thousand pieces that are on
average < 10 kb. Biotinylated linkers are ligated to the
DNA molecules and then digested with the fragmenting
enzyme NlaIII, which has a 4-bp recognition site. DNA
fragments containing biotinlylated linkers are separated
by using streptavidin-coated magnetic beads and are
ligated to new linkers containing a class II MmeI site. The
fragments are then cleaved by MmeI, releasing 21-bp tags.BMC Medical Genomics 2009, 2:22 http://www.biomedcentral.com/1755-8794/2/22
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Isolated tags are self-ligated to form di-tags, PCR-ampli-
fied en masse, concatenated, cloned, and sequenced. The
experimental tags, adjacent to the NlaIII fragmenting
enzyme (CATG) sites closest to SacI mapping enzyme
sites, are computationally extracted from sequence data.
We generated 31 brain tumor, 10 colorectal cancer metas-
tasis, and 7 ovarian cancer DK libraries in our laborato-
ries, and analyzed 10 brain libraries from the Cancer
Genome Anatomy Project http://cgap.nci.nih.gov/SAGE/
DKViewHome.
DK-MICROBE microbial virtual tag library
Generation of an extensive and representative microbial
virtual tag library is essential for implementing the DK-
MICROBE approach. We have assembled a viral and bac-
terial sequence database, which includes all of the com-
plete bacterial http://ftpgib.genes.nig.ac.jp and viral ftp://
ftp.ncbi.nih.gov/refseq/release/viral/ genomes of the
NCBI Reference Sequence (RefSeq) collection as of May 9,
2008. The NCBI RefSeq database is a curated, non-redun-
dant collection of reference sequences for each organism
[26]. Using this database, representative tag sequences
were computationally extracted. The resulting tag collec-
tion contained 21 bp sequences at each NlaIII site closest
to SacI sites for all bacterial or viral genomes in the NCBI
RefSeq collection. Comparison of predicted tag sites from
microbial and human genomes identified minimal over-
lap, as only 1,266 tags were present in both reference
libraries, many of which correspond to common repeti-
tive elements. This suggests that most 21 bp tags contain
sufficient information to distinguish tags as distinctly
human or microbial in origin. The tags which match both
human and microbial genomes were excluded from the
DK-MICROBE virtual tag library for use in further steps of
these analyses. The filtering process removed all tags pre-
dicted in the human genome sequence (Build 36, March
24, 2008). A total number of 664,413 microbial virtual
tags were obtained in this manner. This microbial virtual
tag library (Additional files 1, 2 and 3) allowed us to
quantitatively identify viral or bacterial genomes present
in the analyzed samples by digitally matching experimen-
tally isolated tags to the virtual tags of the reference
library.
DK-MICROBE bioinformatic analyses
Seventeen bp tag sequences (adjacent to NlaIII sites) were
extracted and enumerated. These experimental tags were
linked to the microbial virtual tag library, and only tags
matching microbial sequences perfectly were further con-
sidered. All DK tumor libraries were screened for the pres-
ence of exogenous DNA from viruses or microorganisms.
Foreign genome presence or absence as indicated by DK-
MICROBE was validated by PCR and real-time qPCR.
Selected positive samples were verified by using direct
nucleic acid sequencing.
DK-MICROBE web interface
We have generated a web site that is part of the Cancer
Genome Anatomy Project (CGAP) which allows users to
easily upload and analyze experimental DK-MICROBE
tags for microbial DNA content. A search feature for tags
against microbial genome sequences is available at http:/
/cgap.nci.nih.gov/SAGE/DKMicrobe. Upon uploading a
set of 17 base-pair Digital Karyotyping tags, the DK-
MICROBE tool searches for exact matches to virtual tags in
the genomes of 2,565 bacterial and viral genomes. DK-
MICROBE utilizes the microbial virtual tag library
described and will be updated to reflect new microbial
genome sequences as they become available.
Results
Principles of DK-MICROBE
DK-MICROBE provides an in silico approach to identify
foreign genomic sequences that may be associated with
the host cell in several ways (Fig. 1). For example, micro-
bial DNA may be integrated in the host cell genome, may
persist as extrachromosomal elements, or may be present
in surrounding host tissue. Here, we report an approach
developed on the basis of DK and computational subtrac-
tion for the identification of microbial sequences in
human tissues in any state.
First, the DK-MICROBE approach utilizes the previously
described DK protocol for generation of short sequence
tags from genomic loci [22,25]. Isolated total genomic
DNA is sequentially digested with mapping enzyme SacI,
fragmenting enzyme NlaIII, and the type-IIS tagging
enzyme MmeI to create 21 bp tags that are concatenated
and sequenced to generate a representative genomic pro-
file of the sample. Previous protocols for digital enumera-
tion of DK genomic tags have provided a quantitative
measure for copy number alterations of human loci, and
have been generally used for identification of cancer gene
deletion or amplification [25].
Second, for identification of pathogen genomes in human
tissues, we compiled a database comprising all bacterial
and viral genomes from existing databases and computa-
tionally generated a library that contains microbial virtual
tags. The experimental tags that matched the human
genome or that had no homology to known microbes are
removed such that only exact 21 bp sequences corre-
sponding to the microbial virtual tag library are revealed
and used for further analysis.
Finally, BLAST [27] is used to verify tag matches to micro-
bial genomes and to permit extraction of nearby
sequences for primer design and PCR based confirmation.BMC Medical Genomics 2009, 2:22 http://www.biomedcentral.com/1755-8794/2/22
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Probability of detecting microbial DNA using DK-
MICROBE
The number of microbial tags to be detected within a
given sample by using DK-MICROBE is dependent on the
number of virtual tags that a microbial genome contains
and the microbial load, which represents the contribution
of microbial DNA to the total DNA analyzed. In addition,
the degree of sensitivity and confidence for detection of
microbial DNA in human tissue samples depends on the
total number of tags sequenced. We calculated the proba-
bility of detecting the presence of at least one microbial
tag in a DK library of a given number of total tags
sequenced, for libraries ranging from 50,000 to 2,000,000
tags (Table 1). This analysis showed that detection of a
microbe with a large genome (which theoretically con-
tains a large number of virtual tags) can be achieved with
minimal sequencing when such microbes are present in
virtually all host cells analyzed. For example, viruses or
bacteria with an average of 200 tags per cell can be
detected with > 99% probability by sequencing 50,000
Schematic of DK-MICROBE Figure 1
Schematic of DK-MICROBE. Tissue of interest may have four potential microbial association states: (A) human cells asso-
ciated with surrounding microbes, (B) human cells with integrated foreign DNA, (C) human cells with non-integrated foreign 
DNA, and (D) human cells with no foreign DNA. Sequential restriction digests by SacI (restriction sites indicated by "S") and 
NlaIII (indicated by "N") result in sequence tags derived from foreign DNA sequences (red boxes), and human sequences (blue 
boxes). Small ovals represent linkers while large brown ovals represent streptavidin-coated magnetic beads. Experimental tags 
are matched to microbial virtual tag library, representing all known microbial reference genomes. Unmatched tags include 
human sequences.
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tags. More challenging is the detection of microbes with
small genome size and present with low-level infection.
For example, greater than 2 million tags need to be
sequenced to detect a virus or bacteria at an average of 2
tags per cell with > 99% probability. Due to the scalable
nature of tag sequencing, even a single microbial tag can
be detected by DK-MICROBE when a sufficient number of
tags are analyzed.
Testing the presence of EBV tags in lymphoblastoid lines
To validate the sensitivity and the specificity of the tech-
nology, we evaluated human cell lines with known viral
infections. We first analyzed a normal lymphoblastoid
(NLB) cell line generated through infection with Epstein
Barr virus (EBV) [28]. To identify potential viral or bacte-
rial sequences in the NLB sample, 210,752 tags were
sequenced and were directly matched with the microbial
virtual tag library. Analysis of the NLB library revealed tags
which matched both the EBV strain B95-8 and other EBV-
related viruses. EBV strain B95-8 contains 94 unique tags
and two repetitive tags [29] (Additional file 1). In the NLB
cell line, we identified 2,368 experimental tags distributed
across the EBV genome (Fig. 2). Among the 2,368 tags,
2,002 (85%) tags matched to the 94 unique virtual tags,
with tag numbers ranging from 2 to 59, and 366 (15%)
tags matched to the two repetitive tags. Therefore, all 96 of
the predicted virtual tags were detected by DK-MICROBE,
demonstrating a high level of detection sensitivity. Fur-
thermore, no EBV tags were identified by an analysis of 58
DK libraries derived from tumor samples without any evi-
dence of EBV infection, demonstrating that DK-MICROBE
has high specificity.
Identification of murine retrovirus in xenograft lines
To further investigate the ability of DK-MICROBE to
detect naturally occurring exogenous sequences, we exam-
ined tumor xenograft samples for the presence of murine
retroviruses. It is recognized that xenotropic and ecotropic
murine leukemia viruses (MuLVs) are endemic in nude
mice and can productively infect transplanted tumor cells
[30]. The MuLV genome is approximately 8 kb, giving rise
to only 4 virtual tags per genome. The fewer predicted vir-
tual tags in this genome would make detection of these
viruses more difficult at lower number of experimental
tags than those with larger genomes such as EBV.
We sequenced 136,308 tags from glioblastoma multi-
forme (GBM) xenograft GBMX1 and 92,576 tags from
GBM xenograft GBMX2 and examined these for the pres-
ence of murine retroviruses. DK-MICROBE analysis iden-
tified one tag representing the murine type C retrovirus
(MTCR) reference genome in sample GBMX1. Six copies
of the same tag were identified in GBMX2. PCR analysis
and nucleic acid sequencing surrounding the tag con-
firmed the presence of MTCR (Fig. 3). The tag is located
within the envelope gene of MTCR (data not shown).
Additional PCR analyses based on the MTCR genome
identified MTCR-derived DNA in 100% of 25 brain tumor
xenograft samples but not in primary GBMs (Fig. 3A) or
cell lines (data not shown). Quantitative PCR (qPCR) was
then used to assess relative amounts of viral load between
GBMX1, GBMX2, and a primary tumor sample which did
not contain murine viral tags by DK-MICROBE (Fig. 3B).
We found that the relative viral DNA loading is greater in
GBMX2 than in GBMX1 and absent in the primary GBM,
consistent with the quantitative results obtained from DK-
MICROBE. Similar to the analyses for EBV, MTCR analysis
identified no tags from MTCR in 56 DK libraries derived
from primary tumor samples.
Implementation of DK-MICROBE for screening of human 
cancer samples
To search for the presence of microbial DNA in human
tumors, we used DK-MICROBE to analyze 41 brain tumor
samples (21 adult GBMs, 2 pediatric GBMs, 3 anaplastic
astrocytomas, 1 pediatric astrocytoma, 2 anaplastic oli-
godendrogliomas, and 12 medulloblastomas), 7 ovarian
carcinomas, 3 colorectal carcinomas, and 7 colorectal liver
metastases (Table 2). In total, 8.9 million tags were
sequenced for the 58 tumor samples, with 63,000 to
243,000 tags sequenced per sample.
From all tumor samples, a total of 92 tags were identified
as candidate microbial sequences (Additional file 4).
Among the 92 tags, eight represented murine type C retro-
viruses (7 MTCRs and one Rauscher MuLV) in xenograft
Table 1: Probability of detecting microbial virtual tags using DK-MICROBE
Average microbial tag number per cell Probability of detecting at least one virtual tag given the number of DK tags sequenced (%)^
50,000 100,000 200,000 500,000 1,000,000 2,000,000
2 4.5 8.7 16.7 36.7 59.9 83.9
20 36.7 59.9 83.9 99 100 100
200 99 100 100 100 100 100
^The probability of detecting at least one microbial tag by sequencing r tags is 1 minus the probability of detecting none of the microbial tags among 
m human tags and n microbial tags (1-[m/(m+n)]^r), where m = 2,188,960 (total number of human virtual tags in a diploid genome).BMC Medical Genomics 2009, 2:22 http://www.biomedcentral.com/1755-8794/2/22
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tumors, all of which we validated by PCR against the
MTCR viral genome. Among the remaining tags, only a
few have reported associations with human infection,
including Klebsiella pneumonia [31] and Burkholderia ceno-
cepacia [32]. Several tags represent organisms associated
with host environments other than the human, such as
several plant symbiants and extremophilic species.
Selected tags for the most relevant organisms were chosen
for validation using PCR-based methods. However, these
candidate microbe genomes were not detected in the sam-
ples tested, suggesting that infrequent DK tags matching
exogenous genomic sequences may represent rare con-
taminating DNA sequences which are difficult to amplify,
or may result from sequencing errors or variation in
human genomic sequences that are identical to microbial
sequences.
Three of the unique tags identified matched the Human
herpesvirus 6 (HHV-6) genome. Two of these tags were
each observed twice, one was present only once, and all
were observed in colorectal liver metastasis T4. PCR anal-
ysis using two sets of primers corresponding to the HHV-
6 genome confirmed the presence of HHV-6 genomic
DNA in this sample, as well as corresponding matched
normal tissue from this patient (Fig. 4). Further PCR anal-
yses of additional samples showed that HHV-6 genomic
DNA was present in 3 of 7 colorectal cancer samples, and
5 of the 7 matched normal samples.
Discussion
Microbial pathogens are the etiologic agents of many
human diseases and are likely to be under-appreciated in
other human illnesses, including cancer. The identifica-
DK-MICROBE detection of Epstein-Barr viral sequences in normal lymphoblastoid cells Figure 2
DK-MICROBE detection of Epstein-Barr viral sequences in normal lymphoblastoid cells. Experimental tag counts 
were plotted by position along the EBV strain B95-8 genome. The 366 tags corresponding to EBNA-LP (EBNA leader protein) 
were distributed evenly among 11 repetitive exons, each containing 2 repeated virtual tags.
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tion of previously unrecognized pathogens may advance
the development of new diagnostic methods and may
provide preventative and therapeutic strategies, such as
targeted therapy or vaccines to limit tumor-initiating
infections.
All current technologies for pathogen identification in
human tissues suffer from some common limitations.
Varying mechanisms of infection may confound the iden-
tification of foreign sequences, as the agent may be
present at a very low load in the host cell or function by a
transient (hit-and-run) mechanism. In such cases, success-
ful detection of pathogenic sequences is highly reliant on
infection stage and cellular composition of the sample.
Additionally, these approaches may fail to identify patho-
gens whose genome composition is unknown. Such
methods may also result in false positives, in part because
of the similarity of some microbial sequences with the
sequence of the host cell. Nevertheless, the overall results
of DK-MICROBE indicate a remarkable degree of specifi-
city, even if one assumes that all sequences other than
HHV-6 and murine retroviral tags were the result of non-
microbial sequences (false-positive rate < 0.001% (81/
8,850,672)). As indicated above, the false positives iden-
tified by DK-MICROBE may be a result of homology to
polymorphic human sequences, sequencing errors, or
sequences not present in the current human genome data-
bases.
Identification of murine leukemia virus in xenograft cultures Figure 3
Identification of murine leukemia virus in xenograft cultures. A. PCR detection of murine type C retrovirus (MTCR) 
in brain tumor xenograft cultures and nude mouse, but not primary tumors. B. Comparison between DK-MICROBE tag counts 
and quantitative real-time PCR (qPCR) data. Amplicons surrounding MTCR DK-MICROBE tags were quantified by Q-PCR in 
xenografts GBMX1 and GBMX2 and in negative control primary tumor GBM16. DK-MICROBE tag counts are indicated above 
each bar.
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Table 2: Tumor samples analyzed by DK-MICROBE*
Tumor Type Sample Name Library Origin # Tags Sequenced Total Pathogen Tags
Glioblastoma Multiforme H54OTR Duke 128056 0
H80 CGAP 160995 0
H259 CGAP 199585 1
H270 CGAP 223570 1
H336 CGAP 181478 1
H423 CGAP 170548 4
H502 CGAP 149766 0
H542 CGAP 173466 3
H693 CGAP 210774 1
H1110 CGAP 194089 4
H2620 Duke 79026 9
TB2407 Duke 112358 1
TB2495 Duke 179070 1
TB2507 Duke 63386 0
TB2512 Duke 109182 0
TB2569 Duke 102768 1
TB2580 Duke 134658 0
TB2607 Duke 67042 0
TB2620 Duke 92576 1
TB2721 Duke 110354 0
TB2854 Duke 125282 1
Pediatric Glioblastoma Multiforme H456 Duke 136308 4
TB626 Duke 135562 2
Anaplastic Astrocytoma TB2492 Duke 120466 0
TB2496 Duke 134908 3
TB2677 Duke 129710 2
Pediatric Astrocytoma TB2277 Duke 158294 1
Anaplastic Oligodendroglioma TB2598 Duke 132894 0
TB2741 Duke 127798 0
Medulloblastoma H283 Duke 186836 2
H341 Duke 205402 0
H458 Duke 179686 1
H556 Duke 194696 4
H581 Duke 185934 1
TB771 Duke 243126 3
H876 Duke 157822 0
TB1339 Duke 194998 1
TB1389 Duke 177448 1
TB1961 Duke 183840 2
TB2226 Duke 192046 1
MHH1 CGAP 168562 2
Ovarian Carcinoma 463 JHU 120386 0
505 JHU 125694 1
713 JHU 99782 0
1120 JHU 96666 1
2708 JHU 112912 4
OVCAR-3 JHU 120242 2
SKOV-3 JHU 154098 9
Colon Carcinoma Co84 JHU 142785 1
Co90 JHU 207016 0
Co93 JHU 235632 5BMC Medical Genomics 2009, 2:22 http://www.biomedcentral.com/1755-8794/2/22
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Understanding the advantages and disadvantages of cur-
rent platforms for pathogen identification will help guide
future use and development of these technologies (Table
3). In comparison to expression-based techniques, meth-
ods that use genomic DNA template for pathogen detec-
tion, such as DK-MICROBE, have certain advantages.
Microbial tag representation for DK-MICROBE is based
on genomic length and density of virtual tags within the
genome, whereas expression-based technologies are reli-
ant on the number and level of the transcribed genes.
Therefore, active expression of microbial genes is not
required for detection by DNA-based approaches, and
latent microbial genomic fragments can potentially be
identified. Additionally, using a genomic DNA-based
method allows for utilization of clinical samples not suit-
able for RNA extraction, such as paraffin-embedded fixed
tissue. However, a limitation of using a DNA template is
the assumption that the target pathogen has a DNA
genome or has been covalently integrated into the human
genome. On the other hand, most RNA-based approaches
would miss DNA microbial genomes that are not actively
transcribed. Additional differences can be noted when
considering tag-based platforms against array hybridiza-
tion methods: While an array hybridization technique is
highly versatile in identifying homologous sequences of
microorganisms, current microarray design limits identifi-
cation to a finite number of candidate microbes. On the
other hand, a tag-based like method such as DK-
MICROBE offers a greater chance of identifying rare
microbial associations through extraction of sequences
from specific locations in microbial genomes. However,
tag length may be a limiting factor when working with
novel sequences. With the availability of next generation
high throughput sequencing technologies, the number
and length of tag sequences would be expected to
increase.
Conclusion
In this study, we have developed an unbiased approach
called DK-MICROBE, for discovery of viral and bacterial
associations with human cancer. We validated the sensi-
tivity and specificity of DK-MICROBE in EBV-infected
cells, xenografts, and primary cancer tissues. In the normal
lymphoblastoid cell line, DK-MICROBE detected all vir-
tual tags of EBV which had been used to transform the
cells. In two xenografts, we detected DNA of MuLV, which
has a small genome containing only four virtual tags, but
did not detect this organism in any of the primary tumors
analyzed.
Use of DK-MICROBE identified the presence of HHV-6
DNA in a colorectal cancer metastasis, and subsequent
analyses showed that that viral DNA from HHV-6 is
present in a subset of colorectal tumors and normal tis-
sues from such individuals. These results demonstrate the
ability to discover previously uncharacterized exogenous
DNA in primary cancers and tumor metastases using this
approach. HHV-6 has been reported to infect a variety of
human tissues, and its prevalence in the adult human
population is > 85% [33]. Although our data do not
directly implicate HHV-6 in colorectal tumorigenesis
(since the infection does not appear to be tumor specific),
further studies will be needed to determine whether there
Colon Metastasis (Liver) M10-23 JHU 182482 2
M11-01 JHU 171898 1
M12-02 JHU 210906 1
M12-05 JHU 90780 0
MJC1 JHU 210888 1
MJC3 JHU 135264 1
T4 JHU 118876 4
*Number of tags sequenced and analyzed for each sample are listed by tumor type. Number of tags sequenced and total number of pathogen tags 
detected are indicated for each sample. Pathogen tag sequence origin is listed in Additional file 4. Abbreviations: CGAP, Cancer Genome Anatomy 
Project; JHU, Johns Hopkins University.
Table 2: Tumor samples analyzed by DK-MICROBE* (Continued)
Identification of HHV-6 in colorectal cancer liver metastasis Figure 4
Identification of HHV-6 in colorectal cancer liver 
metastasis. Following identification of HHV-6 by DK-
MICROBE, two non-overlapping primer sets were used for 
PCR confirmation of the presence of HHV-6 DNA in color-
ectal metastasis T4C and in corresponding normal tissue 
T4N.
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Sample:BMC Medical Genomics 2009, 2:22 http://www.biomedcentral.com/1755-8794/2/22
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may be an altered prevalence of colorectal cancer among
HHV-6-infected individuals.
Although the studies performed here with DK-MICROBE
did not clearly implicate a microbial pathogen in the
tumors analyzed, it is clear that this approach has the
power to detect exogenous sequences with high sensitiv-
ity. Given the association of a variety of viral and bacterial
pathogens in the development of human cancer (see [34]
for a recent review), it is likely that additional microbial
culprits remain to be identified in human tumors. This
sensitivity of DK-MICROBE is likely to increase in the
future as next-generation sequencing approaches can be
used to generate tag libraries of substantially greater sizes.
Analysis of larger DK libraries from additional tumor
types and samples will increase the probability of detect-
Table 3: Comparison of available technologies for identification of microbial sequences in human tissues
(A) Genomic DNA-based platform vs. RNA-based platform
Platform Principle for Analysis Advantages Disadvantages References
RNA-based Extraction of sequences from 
expression library data sets
Detection of actively 
expressed microbial genes 
regardless of DNA copy 
number
No detection of non-
transcribed microbial genes
Computational 
Subtraction [14,16]
Tags can be generated as long 
as genes are transcripted
Can miss detection if low 
microbial load
DTS [17,21]
Tag numbers are not limited 
by the genome size
Subject to sequencing errors 
or tag site polymorphisms 
matching microbial 
sequences
Viral Detection DNA 
Microarray [8]
RDA [13]
Genomic DNA-based Extraction of sequences from 
genomic library data sets
Detection of microbial DNA 
regardless of expression 
status of the genes
No detection of non-reverse 
transcribed RNA
DK-MICROBE
Potential to detect latent 
microbial genomic fragments 
which have been integrated 
into human genome
Can miss detection if low 
microbial load
Computational 
Subtraction [15]
Utilization of clinical samples 
not suitable for RNA 
extraction including paraffin-
embedded fixed tissue
Subject to sequencing errors 
or tag site polymorphisms 
matching microbial 
sequences
(B) Tag-based vs. array hybridization
Platform Principle for Analysis Advantages Disadvantages References
Array hybridization Cross hybridization to 
homologous sequences of 
microorganisms on 
microarray
Currently lower cost Array designed to target 
limited number of candidate 
microbes
Viral Detection DNA 
Microarray [8-11]
Method is highly versatile and 
generally high throughput
Risk of unspecific binding
Tag-based Fractional representations 
through extraction of 
sequences from specific 
locations in microbial genomes
Sequence based non biased 
result
Limited by sequencing costs DK-MICROBE
Greater chance to identify 
rare microbial associations
Subject to sequencing errors, 
tag site polymorphisms
Computational 
Subtraction [14-16]
No physical generation of 
organism-specific array
DTS [17,21]
Results can be utilized and 
referenced for additional 
human genome analyses
A. Advantages and disadvantages of using genomic DNA- versus RNA-based platforms. B. Advantages and disadvantages of using tag-based versus 
array hybridization platforms. Abbreviations: DTS, digital transcript subtraction; RDA, representational difference analysis.BMC Medical Genomics 2009, 2:22 http://www.biomedcentral.com/1755-8794/2/22
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ing unrecognized infectious agents that may play a role in
these malignancies. DK-MICROBE may also be useful for
analysis of other human diseases and for analysis of
microbial populations in various microenvironments.
With the complete sequencing of the human genome and
further sequence knowledge of additional microbial
genomes, the utility, sensitivity, and specificity of DK-
MICROBE to detect exogenous sequences will continue to
improve.
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